Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Fig. 3

Association of RVR for SVR 12 with regard to either IFN-containing or IFN-free treatment regime. Association of sustained virological response rates after 12 weeks after the end of treatment (SVR 12) with RVR (level of HCV-RNA either < 12 IU –ml) for patients with HCV genotype 1 infection receiving either SOF + PEG + RBV (a) or SOF + RBV (b). n = number of patients. **p < 0.0001. n.s. = non significant

Back to article page